{
  "id": "ef402f2812cdc753",
  "title": "Opinion: Sidelining Black women in clinical trials is not just a moral failure. It\u2019s bad science",
  "description": "When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete.",
  "content": "When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/27/breast-cancer-disparities-clinical-trial-research-black-women-asco-inavolisib/?utm_campaign=rss",
  "published_at": "2026-01-27T09:30:00+00:00",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "Opinion: Sidelining Black women in clinical trials is not just a moral failure. It\u2019s bad science",
    "description": "When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete.",
    "url": "https://www.statnews.com/2026/01/27/breast-cancer-disparities-clinical-trial-research-black-women-asco-inavolisib/?utm_campaign=rss",
    "published": "2026-01-27T09:30:00+00:00",
    "source": "STAT"
  }
}